默克雪兰诺

Quintiles also will be a key contributor to Merck Serono´s future clinical trial design activities.

昆泰也将成为默克雪兰诺未来临床试验设计活动中的一个关键因素。

Moving forward, Quintiles will be the sole primary provider of Merck Serono´s outsourced clinical development services for its global clinical programs.

展望未来，昆泰将成为默克雪兰诺全球临床项目外包临床开发服务唯一的主要提供者。

To fully leverage the expertise of both organizations, leaders from Quintiles will collaborate in strategic decision-making processes affecting the development of the Merck Serono portfolio.

为了充分利用双方的专业知识，昆泰领导层将参与协作默克雪兰诺产品组合开发的战略决策过程。

Under this agreement, Merck Serono will shape and lead the strategy of its clinical development programs, with Quintiles directing clinical trial planning and execution.

根据该协议，默克雪兰诺将塑造并领导其临床开发项目的战略，昆泰则指导临床试验的规划和执行。

With this complete portfolio, Merck Serono offers physicians the ability to tailor treatment to individual patients.

有了这个完整的产品组合，默克雪兰诺给医生向不同病人提供个性化治疗的能力。